|
HNRNPM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11069999997326E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.2699999996666E-07 |
| Normal-vs-Stage2 |
2.00689999999559E-05 |
| Normal-vs-Stage3 |
2.487800E-02 |
| Normal-vs-Stage4 |
3.62740000000583E-05 |
| Stage1-vs-Stage2 |
4.774000E-01 |
| Stage1-vs-Stage3 |
2.838000E-01 |
| Stage1-vs-Stage4 |
3.254800E-01 |
| Stage2-vs-Stage3 |
1.857960E-01 |
| Stage2-vs-Stage4 |
6.313200E-01 |
| Stage3-vs-Stage4 |
1.590990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74569999999985E-06 |
| Normal-vs-AfricanAmerican |
4.19959999999886E-05 |
| Normal-vs-Asian |
2.977300E-03 |
| Caucasian-vs-AfricanAmerican |
6.877600E-01 |
| Caucasian-vs-Asian |
5.965600E-01 |
| AfricanAmerican-vs-Asian |
6.449400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89779999785145E-08 |
| Normal-vs-Female |
2.938100E-02 |
| Male-vs-Female |
1.838720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.41799999999293E-05 |
| Normal-vs-Extreme_Weight |
4.38219999954192E-07 |
| Normal-vs-Obese |
3.612700E-04 |
| Normal-vs-Extreme_Obese |
4.022000E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.828000E-01 |
| Normal_Weight-vs-Obese |
2.203200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.922800E-01 |
| Extreme_Weight-vs-Obese |
1.603010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.683600E-01 |
| Obese-vs-Extreme_Obese |
2.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.082000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.42849999999573E-05 |
| Normal-vs-Age(61-80Yrs) |
6.52310000015532E-07 |
| Normal-vs-Age(81-100Yrs) |
2.34519999999794E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.641050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.895900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.570360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.669400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.145770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.786570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.17389999999496E-05 |
| Normal-VS-Type2 PRCC |
1.99030003589229E-09 |
| Normal-VS-KIRP CIMP |
2.612200E-01 |
| Normal-VS-Unclassified PRCC |
1.836480E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.202510E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.609000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.991000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.601800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.387900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.214600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.32140000011994E-07 |
| Normal-vs-N1 |
3.422400E-01 |
| Normal-vs-N2 |
7.577000E-04 |
| N0-vs-N1 |
6.564100E-03 |
| N0-vs-N2 |
4.234400E-01 |
| N1-vs-N2 |
1.031010E-01 |
|
|
